Search
for

    Sort by

    Research 541–570 of 1000+

    1. An exploration into the management and diagnosis of Polycystic Ovarian Syndrome by Complementary and Alternate Medical (CAM) practitioners in the eThekwini area 2021
    2. Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study Research Square (Research Square) · 2021
    3. Study of cutaneous manifestations in patients with polycystic ovarian syndrome attending a tertiary care centre International Journal of Research in Dermatology · 2019
    4. AKT2 Gene Polymorphisms, sRANKL/OPG and Hormone Measurements in Polycystic Ovarian Syndrome (PCOS) Women Clinical & medical biochemistry · 2017
    5. Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years Journal of SAFOG · 2016
    6. Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association? Endocrinología y nutrición · 2014
    7. The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results Fertility and Sterility · 2013
    8. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome European journal of cancer · 2016 · 294 citations
    9. Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study Annals of Oncology · 2007 · 29 citations
    10. Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome Fertility and Sterility · 2013 · 6 citations
    11. Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome JBRA assisted reproduction · 2018 · 4 citations
    12. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study. 1994 · 2 citations
    13. Reproductive health screening for endometriosis, reduced ovarian reserve, polycystic ovary syndrome and the most common sexually transmitted diseases Medicinski pregled · 2024 · 1 citations
    14. ANTI-MÜLLERIAN HORMONE LEVEL AS A PREDICTIVE FACTOR IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME IN DUHOK PROVINCE – KURDISTAN REGION, IRAQ Duhok Medical Journal · 2023 · 1 citations
    15. Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization Biomolecules · 2026
    16. EFFECT OF THYROID DYSFUNCTION ON BODY MASS INDEX AND HORMONAL IMBALANCE IN WOMEN HAVING POLYCYSTIC OVARIAN SYNDROME Biological and Clinical Sciences Research Journal · 2024
    17. A study to evaluate the effectiveness of informative educational approach on knowledge regarding polycystic ovarian syndrome, it’s impact on reproductive system and preventive strategies among adolescent girls at selected colleges, Koppal district IP Journal of Nutrition Metabolism and Health Science · 2024
    18. Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome? Authorea (Authorea) · 2024
    19. DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN Journal of the ASEAN Federation of Endocrine Societies · 2023
    20. Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome? Biomedical reports · 2022
    21. Effect of Acupressure on Health-Related Quality of Life in Patients with Polycystic Ovarian Syndrome: A Randomized Clinical Trial Evidence-based complementary and alternative medicine · 2022
    22. METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE Fertility and sterility · 2021
    23. Use of Finasteride- Oral Contraceptive Pill Combination in the Treatment of Polycystic Ovarian Syndrome Related- Infertility Medical Journal of Babylon · 2012
    24. Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien Online Publication Service of Würzburg University (Würzburg University) · 2004
    25. Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach Journal of drug delivery science and technology · 2023 · 3 citations
    26. 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011) Annals of Oncology · 2022 · 2 citations
    27. Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism” International Journal of Dermatology · 2021 · 1 citations
    28. Knowledge, Attitude, and Practice of Polycystic Ovarian Syndrome Diagnosis among Health Care Providers in Addis Ababa, Ethiopia BMC Women s Health · 2025
    29. Study the correlation between Helicobacter pylori and insulin resistance in a group of women with polycystic ovarian syndrome in Baghdad city ASEAN Journal of Psychiatry · 2024
    30. Comparative analysis between ethinyl estradiol & cyperoterone acetate with or without metformin therapy in the treatment of polycyctic ovarian syndrome induced hirsutism Journal of Pakistan Association of Dermatologists · 2017